Introduction
Clenbuterol is used in asthma treatment because it produces relaxation of the bronchial smooth muscle, and thereby decreases airway resistance. However, it is now well-known that at comparatively high doses it can be used as a repartitioning or fattening agent, because it promotes the use of fat and the deposition of protein in the muscle. For this reason, clenbuterol is often used illegally as a growth-promoting agent to improve the efficiency of feed conversion, and to enhance the lean meat to fat ratio in many species, including cattle, sheep, pig, poultry and man. If clenbuterol is given to pigs during the growth process, the produced meat might contain residues of clenbuterol, which can lead to food poisoning. [1] [2] [3] [4] The growth promoter has therefore been forbidden in many countries.
Several analytical methods have already been developed to monitor clenbuterol at the mg kg -1 level in tissues, including biological fluids by using immunoassays 5, 6 and HPLC with UV, electrochemical or fluorescence detection. [7] [8] [9] These analytical methods are technically complex, or time-consuming, or costly. Therefore, the development of a rapid and sensitive method for the quantitative analysis of clenbuterol in food of animal origin is required. Fluoroimmunoassay methods, due to being its simple, selective and cost-effective, have been increasingly employed. 10 Semiconductor quantum dots (QDs) have unique photophysical properties, including broad absorption and narrow emission spectra, large extinction coefficients, resistance to photobleaching, a long fluorescence lifetime, and size-tunable emission. These unique properties provide important advantages over organic dyes and lanthanide probes in fluorescence labeling applications, resulting in an increased use of QDs as fluorescent labels in immunoassays. [11] [12] [13] Several immobilization methodologies are available for antibody or antigen immobilization. These methodologies are mainly based on chemical and physical mechanisms. In general, chemical immobilization can provide strong stable protein attachment, but may perturb the protein native structure. The physical immobilization approach may perturb the protein much less, but provide short-time activity retention. 14 Magnetic nanoparticles, such as magnetic core/shell Fe3O4/Au nanoparticles (MCFN), have already been successfully used in various fields of biology and medicine, such as magnetic targeting (of drugs, genes), magnetic resonance imaging, immunoassays, cell separation, RNA and DNA purification, [15] [16] [17] [18] owing to their unique higher dispersion capability in aqueous solution, and higher separation efficiency in a magnetic field and easy operation in auto-workstations. It is very simple if magnetic nanoparticles are used as an alternative protein immobilization matrix.
In this paper, we report on a novel method for the determination of clenbuterol residue in pig urine using CdSe/CdS quantum dot-based competitive fluoroimmunoassay with MCFN as a solid carrier. The method shows a wide linear working range of 0.5 -20000 pg mL -1 with a very low detection limit. . It would provide a simple, rapid, and ultra-sensitive detection method for clenbuterol or other biomolecular analysis. 
Apparatus
A WFY28 fluorescence spectrophotometer (Tuopu Instrument Co., Ltd., Tianjin, China) was used to obtain fluorescence signals. UV-vis absorption spectra were acquired on a TU-1901 UV-vis spectrometer (Purkinje General Instrument Co. Ltd., China). A transmission electron micrograph (TEM) was recorded with a Tecnai G220 electron microscope (FEI Co. Ltd., USA) operating at 200 kV. Fluorescence images were taken with an Olympus IX71 fluorescent microscope (Olympus Optical Co. Ltd., Japan). A C18 column (4.6 × 250 mm, particle size 5 μm) was purchased from Welch Materials, Inc., USA.
Solutions
A stock solution (1 μg mL -1
) of clenbuterol was prepared by dissolving an appropriate amount of clenbuterol in phosphate buffer (pH 7.4). A working solution (100 ng mL -1 ), prepared by 10-fold dilution of the stock solution, was stored at 4 C until being used. Standard solutions were prepared by a series of dilutions from the working solution. All clenbuterol solutions were diluted in 10 mM phosphate buffer (pH 7.4) under different concentrations.
Preparation of CdSe/CdS nanocrystals
CdSe/CdS nanocrystals were prepared using a method described by Yang et al. 19, 20 A typical synthetic procedure of the CdSe nanocrystals is briefly described below. First, 20 mmol of CdO, 9.6 mL of oleic acid, and 40 mL of paraffin liquid were loaded into a three-neck flask. At 150 C, a reddish CdO powder was dissolved gradually, and a daylight yellowish homogeneous solution (solution A) was generated. Then, 1 mmol of Se powder in 50 mL of paraffin liquid was carefully heated to 220 C with rapid stirring (solution B) in another three-necked flask. The solution turned orange, and then wine red. Then, 5 mL of solution A (containing 2 mmol of Cd precursor) was swiftly injected into solution B while the mixture was being strongly stirred. After injection, the temperature was dropped to 210 C immediately, and then rose to 220 C in 0.5 min. The final temperature was maintained at 220 C for the growth of CdSe nanocrystals. The synthesis could be carried out under nitrogen protection.
The core-shell CdSe/CdS QDs were obtained by adding different amounts of sodium sulfide powder into a CdSe solution while being stirred strongly, and then cooled to room temperature.
The surface-ligand exchange of CdSe/CdS with 2-mercaptoacetic acid made the QDs water soluble in a basic aqueous solution.
The procedure for the surface-ligand exchange was similar to that reported elsewhere. 21 Firstly, a CdSe/CdS solution was dissolved in hexane. Then, an excess amount of 2-mercaptoacetic acid was added into the QDs solution, and an instant formation of precipitate could be observed. Finally, this precipitate was isolated from solvents and unreacted reagents via centrifugation at 5000 r min -1 for 5 min after 30 min of stirring. After washing three times with hexane, it was dried with nitrogen purge. The dried powder of QDs was then dispersed in 50 mmol L -1 phosphate buffer (pH 7.4) to obtain a clear solution. Insoluble substances were removed by centrifugation, if necessary. The solution was kept at 4 C until being used. A TEM image of the synthesized CdSe/CdS QDs is shown in Fig. 1 . The average size of CdSe/CdS QDs nanoparticles is approximately 5 -6 nm.
Labeling clenbuterol antigen with CdSe/CdS QDs
After 200 μL of a CdSe/CdS QDs solution was diluted in 1 mL of a phosphate buffered solution (pH 7.4), 200 μL of 1 mg mL -1 of a clenbuterol antigen solution was added. The mixture was incubated at 37 C for 2 h and 4 C overnight. At last, the labeled clenbuterol antigen was washed by repeated centrifugation (12000 rpm) in a 100 kD ultrafiltration tube (Centricon YM-100, Millipore Corp., USA) at 24 C for 30 min with a 10 mM phosphate buffer (pH 7.4). The unbound antigen and CdSe/CdS QDs was washed away. The precipitate was re-suspended in phosphate buffer (pH 7.4) and stored at 4 C for use.
Clenbuterol antibodies immobilized on MCFN
A MCFN suspension was washed three times with 500 μL phosphate buffer (pH 7.4), containing 0.05% Tween-20 by centrifugation, and re-dispersed with 10 mM phosphate buffer (pH 7.4) containing 1% bovine serum albumin and 0.1% sodium azide. A clenbuterol antibody solution was added, and incubated at 37 C for 1 h and 4 C overnight. After this procedure, the modified particles were collected by magnetic force, washed, and re-dispersed with 10 mM phosphate buffer (pH 7.4). The solution contained 100 μg mL -1 antibody.
Treatment of pig urine
Pig urine samples were treated mainly according to a reported method. 22 A C18 column was prepared before the actual extraction was started. The column was rinsed with 6 mL of 100% methanol. After methanol had been eluted, the column was rinsed with 4 mL of deionized water. The column was later equilibrated with 2 mL of 50 mM potassium dihydrogenphosphate (KH2PO4) buffer (pH 3). After the equilibration was completed, 1 mL of urine sample, which had been added with the clenbuterol solution, was loaded, and the column was rinsed with 2 mL of 50 mM KH2PO4 buffer. The sample was eluted with 1 mL of a methanol/water mixture (50/50, v/v). The eluate was evaporated under a vacuum, and the residue was dissolved in 1 mL of deionized water for detection. Therefore, the quantification of clenbuterol was made possible by detecting the relative fluorescent intensity of unbound antigen-CdSe/CdS conjugates (Fig. 2) .
Detection of clenbuterol by fluoroimmunoassay
After 40 μL of antibody immobilized on MCFN was added in each tube (1.5 mL), 50 μL of concentrated antigen conjugates was added one by one in each tube. Respectively, to some tubes, 20 μL of different concentration standard solutions or 20 μL of pre-treated pig urine was added. Then the contents were thoroughly mixed and left to incubate for some time at 37 C. Some antigen and clenbuterol molecules were bound to the immobilized antibodies. The MCFN suspension was collected by magnetic force.
The unbound clenbuterol antigen-CdSe/CdS, which was in excess, was left in the solution. The rest of the solution was pipetted and analyzed by a fluorescence spectrophotometer.
Results and Discussion

Fluorescence spectroscopy measurements of CdSe/CdS QDs and antigen-QDs
The emission spectra of CdSe/CdS QDs and the clenbuterol antigen-QDs were measured. All samples were excited at 400 nm; emission scans were measured from 540 to 700 nm in a 1-cm cell. Figure 3 shows the FL spectra of CdSe/CdS QDs and antigen-QDs. It can be seen that the emission peak of the antigen-QDs is 8 nm red-shifted as compared to CdSe/CdS QDs, which is caused by the increased size of the clenbuterol antigen.
The UV-vis absorption spectrum of quantum dot offers a simple way to investigate their band structure and band-gap energy. This in turn provides a way to determine the resonance energy transfer coupled with biomolecular conjugation. The absorption spectra of the CdSe/CdS QDs and the clenbuterol antigen-QDs conjugate were recorded (Fig. 4) . The peak shows a considerable 6 nm blue-shifted (from 552 nm to 546 nm). This suggests that interactions take place between the CdSe/CdS QDs and the clenbuterol antigen-QDs. Figure 5 shows fluorescence images of CdSe/CdS QDs (A), clenbuterol antigen (B) and clenbuterol antigen-QDs (C). As described concerning in labeling clenbuterol antigen with CdSe/CdS QDs in experimental, after labeling, the solution was subjected to repeated centrifugation in a 100 kD ultrafiltration tube. The excess QDs and unbound antigen were thus removed from the solution. Only QDs-antigen conjugation remained. Therefore, the images shown in Fig. 5C could demonstrate that the antigen had been labeled by CdSe/CdS QDs.
Effect of the incubation time on fluorescence intensity
For antibody immobilization on MCFN, clenbuterol antigen-QDs and clenbuterol were incubated over times ranging from 1 to 36 h at 37 C. The contents were collected by magnet force. The remainder of the solution was pipetted and analyzed by a fluorescence spectrophotometer at different incubation times (1, 2, 4, 8, 12, 16, 24, 36 h) . The change in the fluorescence intensity with the incubation time is shown as , CdSe/CdS QDs; , antigen; , clenbuterol; , antibody; , MCFN. 
23-25
The existence of ions in solution may lead to the fluorescence of clenbuterol antigen-QDs quenching. Thus, the incubated time was fixed to 2 h.
Method sensitivity and specificity
The immunoassay development was based on the optimization of several parameters to achieve high sensitivity of detection using a quantum dot-based analytical system. It has been reported that the specificity of immunoassay generally depends on the immunogenic nature of the hapten, and that the competitiveness of the hapten determines the sensitivity of the immunoassay. 26 It was observed that with increasing concentrations of clenbuterol (0.5 to 20000 pg mL -1 range), the fluorescence intensity was increased (Fig. 7) . A calibration graph, plotted with clenbuterol in the concentration range 0.5 to 20000 pg mL -1 against the relative fluorescence intensity, obeyed the equation I = 70.56 + 11.79 × log C (r = 0.992), where I represents the fluorescence intensity and C is the concentration of clenbuterol in pg mL -1 . The detection limit of the system was 0.5 pg mL -1 .
Sample analysis
The clenbuterol was determined according to the developed method. A standard clenbuterol solution and pre-treated pig urine were added for a recovery experiment. Details of the recovery are presented in Table 1 .
Recoveries of 87.50 to 116.7% by the fluoroimmunoassay method were achieved. This indicated that the method was sufficiently accurate, sensitive and valid for further applications in pig urine samples. Table 2 gives the values of clenbuterol concentrations in samples measured by the developed methods and HPLC 
Conclusions
In this paper, CdSe/CdS QDs were synthesized and used successfully as a novel sensitive and selective sensor for the determination of clenbuterol. The method provides a fairly practical and ultra-sensitive approach. QDs can be used for future biosensor developments for the rapid and sensitive detection of food and environmental monitoring. In addition, MCFN was successfully applied as solid carriers in the developed method. It could be expected that magnetic particles will be used more widely in analytical fields in the near future.
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